India looks to Italy as way to move away from Chinese APIs; China expects its domestic industry to grow;

> India is looking to API producers in Italy to reduce its reliance on Chinese companies. Report

> Dalton Pharma Services says Health Canada has found its API manufacturing operations "compliant" with its new guidance. Release

> A new report from CPhI says Chinese drugmakers, on average, expect to see their sales double in the next 5 years, as the cost advantages for API making in the country continue to play out. Report

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.